score_bin	sensitive_predictive_implication	resistance_predictive_implication	prognostic_predictive_implication	feature_type	feature	alteration_type	alteration	tumor_f	total_coverage	exac_af	exac_common	clinvar	sensitive_score_bin	sensitive_therapy_name	sensitive_therapy_strategy	sensitive_therapy_type	sensitive_description	sensitive_citation	sensitive_url	resistance_score_bin	resistance_therapy_name	resistance_therapy_strategy	resistance_therapy_type	resistance_description	resistance_citation	resistance_url	prognostic_score_bin	favorable_prognosis	prognostic_description	prognostic_citation	prognostic_url	number_germline_mutations_in_gene	validation_total_coverage	validation_tumor_f	validation_detection_power	feature_display	preclinical_efficacy_observed	patient_id	tumor_sample_barcode	normal_sample_barcode
Putatively Actionable		Preclinical		Copy Number	KEAP1	Deletion				0.0	0.0									Putatively Actionable	Radiation therapy	Radiation	Radiation therapy	In a mouse model of lung scamous cell carcinoma, deletion of KEAP1 promoted tumor aggressiveness, metastasis, and resistance to oxidative stress and radiotherapy (RT). KEAP1 / NRF2 mutation status predicted risk of local recurrence after RT in patients with non-small lung cancer (NSCLC).	Jeong Y, Hoang NT, Lovejoy A, et al. Role of / and Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance Cancer Discov. 2017; 7(1):86-101.	https://doi.org/10.1158/2159-8290.cd-16-0127						0				KEAP1 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Investigate Actionability	Preclinical			Copy Number	CCNE1	Deletion				0.0	0.0		Investigate Actionability	Bortezomib	Proteasome inhibition	Targeted therapy	Sensitivity to Bortezomib was observed in ovarian cancer cell lines.	"Etemadmoghadam, Dariush, et al. ""Synthetic lethality between CCNE1 amplification and loss of BRCA1."" Proceedings of the National Academy of Sciences 110.48 (2013): 19489-19494."	https://doi.org/10.1073/pnas.1314302110													0				CCNE1 Deletion	1.0	KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Somatic Variant	TACC3	Missense	p.Q119E	0.51	100.0	0.0	0.0																					0	0.0	0.0	0.0	TACC3 p.Q119E (Missense)		KIRP-2Z-A9JQ	KIRP-2Z-A9JQ-TP	KIRP-2Z-A9JQ-NB
Biologically Relevant				Somatic Variant	TACC3	Missense	p.Q119L	0.505	101.0	0.0	0.0																					0	0.0	0.0	0.0	TACC3 p.Q119L (Missense)		KIRP-2Z-A9JQ	KIRP-2Z-A9JQ-TP	KIRP-2Z-A9JQ-NB
Biologically Relevant				Copy Number	POLD1	Deletion				0.0	0.0																					0				POLD1 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	JAK3	Deletion				0.0	0.0																					0				JAK3 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	IL12RB1	Deletion				0.0	0.0																					0				IL12RB1 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	MAP2K2	Deletion				0.0	0.0																					0				MAP2K2 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	SMARCA4	Deletion				0.0	0.0																					0				SMARCA4 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	BRD4	Deletion				0.0	0.0																					0				BRD4 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	AKT2	Deletion				0.0	0.0																					0				AKT2 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Copy Number	ERCC2	Deletion				0.0	0.0																					0				ERCC2 Deletion		KIRP-2Z-A9JQ	TCGA-2Z-A9JQ-01	
Biologically Relevant				Mutational Signature	COSMIC Signature 24	version 2	0.211																									0				COSMIC Signature (version 2) 24 (21%)		KIRP-2Z-A9JQ		
